The ROE as of November 2024 (TTM) for Shionogi & Co., Ltd. (SGIOF) is 12.23%

According to Shionogi & Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 12.23%. This represents a change of 298.70% compared to the average of 3.07% of the last 4 quarters.

Shionogi & Co., Ltd. (SGIOF) Historical ROE (quarterly & annually)

How has SGIOF ROE performed in the past?

The mean historical ROE of Shionogi & Co., Ltd. over the last ten years is 14.72%. The current 12.23% ROE has changed -16.95% with respect to the historical average. Over the past ten years (40 quarters), SGIOF's ROE was at its highest in in the December 2022 quarter at 9.52%. The ROE was at its lowest in in the September 2014 quarter at -0.13%.

Shionogi & Co., Ltd. (SGIOF) ROE by Quarter and Year

Discovering the peaks and valleys of Shionogi & Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shionogi & Co., Ltd. (SGIOF) Average ROE

How has SGIOF ROE performed in the past?

The current ROE of Shionogi & Co., Ltd. (SGIOF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Shionogi & Co., Ltd. (SGIOF) ROE vs. Peers

How is SGIOF’s ROE compared to its peers?

Shionogi & Co., Ltd.’s ROE is less than Taisho Pharmaceutical Holdings Co., Ltd. (1.04%), greater than Vivesto AB (-47.38%), less than Acorda Therapeutics, Inc. (485.80%), less than Pacira BioSciences, Inc. (7.32%), less than Shionogi & Co., Ltd. (12.23%), greater than Sunshine Biopharma, Inc. (-16.09%), greater than Alimera Sciences, Inc. (-33.70%), greater than China SXT Pharmaceuticals, Inc. (-83.62%), greater than Guardion Health Sciences, Inc. (-71.26%), greater than Cresco Labs Inc. (-35.86%), greater than Curaleaf Holdings, Inc. (-24.52%), greater than Trulieve Cannabis Corp. (-7.49%), less than Journey Medical Corporation (5.44%), greater than Aurora Cannabis Inc. (-118.26%), greater than Ironwood Pharmaceuticals, Inc. (-2.78%), greater than Assertio Holdings, Inc. (-231.03%), less than Neurocrine Biosciences, Inc. (15.68%), greater than Deciphera Pharmaceuticals, Inc. (-52.42%), less than Esperion Therapeutics, Inc. (26.20%),

Build a custom stock screener for Shionogi & Co., Ltd. (SGIOF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shionogi & Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shionogi & Co., Ltd. (SGIOF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shionogi & Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.